[Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to evaluate the quality of observations].
Benoit
M
M
Hôpital Pasteur, Service du Pr D Pringuey, Nice.
Pon
J
J
Zimmermann
M A
MA
D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002908:Chronic Disease; D003692:Delayed-Action Preparations; D006801:Humans; D008134:Long-Term Care; D010342:Patient Acceptance of Health Care / Q000523:psychology; D010349:Patient Compliance / Q000523:psychology; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations